Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.880
-0.030 (-1.57%)
At close: Sep 8, 2025, 4:00 PM
1.860
-0.020 (-1.06%)
After-hours: Sep 8, 2025, 4:46 PM EDT
Metagenomi Market Cap
Metagenomi has a market cap or net worth of $70.56 million as of September 8, 2025. Its market cap has decreased by -42.87% in one year.
Market Cap
70.56M
Enterprise Value
-92.19M
1-Year Change
-42.87%
Ranking
Category
Stock Price
$1.88
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi's market cap has decreased from $562.92M to $70.56M, a decrease of -87.46%. That is a compound annual growth rate of -73.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 71.69M | -46.94% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |